Mapping Transmission Core Areas Boosts Targeted Hepatitis C Therapy

Mapping techniques for identifying ‘core areas’ for transmission of bacterial sexually transmitted diseases have now been applied to hepatitis C virus (HCV) infections by Canadian investigators, who anticipate this approach will facilitate HCV prevention and intervention programs.

Zahid Butt, PhD, MSc, of the School of Population and Public Health at the University of British Columbia, lead a team seeking analysis on the application of core theory and spatial analysis to HCV infections, told MD Magazine® that he expects that the mapping techniques will yield significant public health benefits.

"They can guide HCV prevention and care services such as needle and syringe distribution, supervised consumption sites, and overdose prevention sites, which can help reduce the incidence of HCV in the community," Butt said. "Additionally, they can optimize resource allocation and guide service delivery such as HCV treatment to these areas to reduce transmission of HCV."

Butt and colleagues point out that while spatial epidemiological research with HCV has delineated ‘hot spots’ for infection, it has not previously differentiated between geographic clusters and core areas.

"For effective HCV prevention and intervention planning, it is essential to know if a geographic cluster of HCV infection is a core area, non-core area or outbreak cluster, indicated by its stability and persistence over time and space," the investigators explained.

Time is essential for defining core areas, with such areas reflecting sustained and persistent infections of periods of 5 years or longer, in contrast to non-core areas or areas of outbreaks of shorter duration.

Butt and colleagues identified a total of 65,283 cases of diagnosed HCV from the British Columbia (BC) Hepatitis Testers Cohort (BH-HTC), which comprised an approximate 1.5 million BC residents who were tested for HCV between 1990-2103. They stratified the incidence data into 5 time periods of several years each to ascertain the temporal component of infection transmission; and applied 4 methods of spatial analysis to ascertain the geographic component that, together, could define core areas for HCV infection.

The investigators found good consistency across the 4 methods used for spatial mapping of core areas. There were significant clustering of HCV cases primarily in urban areas, but also in population centers supporting rural and remote communities. One major cluster of HCV transmission in Greater Vancouver was found to have persisted for nearly 20 years.

They point out that identifying non-core areas in the process is also important from a surveillance standpoint, as these could become core areas if appropriate interventions to address causes of outbreak or higher transmission are not implemented.

"As this method can be integrated into health systems, core areas can be used for evaluation of HCV prevention/elimination programs and their impact over time," Butt told MD Magazine®. "Real time application of core area methodology can help in identifying new HCV cases and outbreaks, gaps in services, testing and treatment of HCV and evaluation of services over time."

The study, Applying Core Theory and Spatial Analysis to Identify Hepatitis C Virus Infection "Core Areas" in British Columbia, Canada, was published online in the Journal of Viral Hepatitis.
 
 
This article was originally published by MD Magazine.




Stay up to date on the latest news in specialty pharmacy by getting Specialty Pharmacy Times in your mailbox or inbox for free!

Click here to sign up for free for the bi-monthly Specialty Pharmacy Times print journal delivered to your address.

Click here to sign up for our email newsletters delivered every Monday, Wednesday, and Friday, in addition to breaking news alerts.

Click here to follow us on Facebook. 

Click here to follow us on Twitter. 

Click here to join our LinkedIn group. 


Most Popular

Related Articles

Longitudinal study of direct-acting antivirals for hepatitis C virus infection finds that treatment provides clinical benefit beyond virologic response, reducing risk for both all-cause mortality and for liver cancer.
A novel method of inactivating hepatitis C virus in donor lungs could increase transplantations for patients with end stage lung disease.
Sofosbuvir-based regimens for the treatment of hepatitis C were well tolerated in Asian American communities, according to a new study.
Company Profile >
Industry Guide >
Market News >
Peer Exchange >
Conferences >
Subscribe >
Specialty Times Resources
About Us
Advertise
Careers
Contact Us
Terms & Conditions
Privacy
MJH Associates >
Pharmacy Times
OTCGuide
American Journal of Managed Care
Cure
MD Magazine
ONCLive
Targeted Oncology
Physicians' Education Resource
Pharmacy & Healthcare Communications, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747

Copyright Specialty Pharmacy Times 2006-2018
Pharmacy & Healthcare Communications, LLC. All Rights Reserved.
 

$vacMongoViewPlus$